Cafepharma Today

June 11 2025 - BMS expands radiopharma pipeline via RayzeBio's $1.3B prostate cancer drug deal
BMS expands radiopharma pipeline via RayzeBio's $1.3B prostate cancer drug deal
Novo Nordisk, Deep Apple launch drug discovery alliance for weight loss oral therapies
Eli Lilly works out $650M Juvena pact to find muscle-boosting drugs
Nvidia announces massive new initiatives in pharma and clinical research
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

A Victory For Gilead
Forbes
Friday, March 4, 2011 - 1:01pm
tags:
Gilead Sciences, Myogen, HIV
BioSante expects to support drug study program with $23.8 million from direct stock offering
Yahoo/AP
Friday, March 4, 2011 - 1:00pm
tags:
BioSante, stock offering, Pfizer
Genzyme CEO: Sanofi to create jobs
Boston Herald, MA
Friday, March 4, 2011 - 10:44am
tags:
M&A, Genzyme, Sanofi, Henri Termeer
Merck Discriminated Against A Non-Hispanic Worker?
Pharmalot
Friday, March 4, 2011 - 10:42am
tags:
Merck, discrimination
Vivus Shares Fall 13 Percent After FDA Topamax Risk Warning
Bloomberg
Friday, March 4, 2011 - 10:40am
tags:
Vivus, birth defects, Topamax, JNJ, Qnexa
Somaxon's 4Q loss widens on higher costs
Yahoo/AP
Friday, March 4, 2011 - 10:39am
tags:
earnings, Somaxon
Sucampo reports loss on revenue dip, higher costs
Yahoo/AP
Friday, March 4, 2011 - 10:38am
tags:
earnings, Sucampo
No Serendipity Involved in Vertex's Achievements
Seeking Alpha
Friday, March 4, 2011 - 10:37am
tags:
Vertex Pharmaceuticals, VX-770, cystic fibrosis
Novartis Lung Treatment Faces Scrutiny in Second Review by FDA
Bloomberg
Friday, March 4, 2011 - 10:36am
tags:
Novartis, FDA, Arcapta Neohaler, asthma
Pfizer Says Primary Goal Met in Tofacitinib Trial
Bloomberg
Friday, March 4, 2011 - 10:34am
tags:
Pfizer, rheumatoid arthritis, tofacitinib
Pfizer: The Market's Undervalued Ugly Duckling
Seeking Alpha
Friday, March 4, 2011 - 10:33am
tags:
Pfizer, Lipitor
FDA warns of birth defects with Topamax
Yahoo/AP
Friday, March 4, 2011 - 10:33am
tags:
FDA, Topamax, epilepsy, birth defects
Pfizer to Aid Aurobindo Resolve U.S. Regulatory Issues, PTI Says
Bloomberg
Friday, March 4, 2011 - 10:31am
tags:
Pfizer, Aurobindo, India, FDA
Peter Rost Takes Another Whack At Pfizer
Pharmalot
Thursday, March 3, 2011 - 6:47pm
tags:
Peter Rost, Pfizer, whistleblowers
The Vioxx Endgame: It’s All About the Fees
WSJ Online
Thursday, March 3, 2011 - 6:45pm
tags:
Vioxx, Merck, settlements
3 Biotechs With Upcoming Catalysts
Seeking Alpha
Thursday, March 3, 2011 - 5:59pm
tags:
Aastrom, Cleveland BioLabs, Spectrum Pharmaceuticals
InterMune Surges on EC Drug Approval
Barron's
Thursday, March 3, 2011 - 5:57pm
tags:
InterMune, Esbriet, IPF, Europe
Buy Bristol-Myers Calls as Stock May Advance, Goldman Says
Bloomberg
Thursday, March 3, 2011 - 5:52pm
tags:
Bristol-Myers Squibb, melanoma, ipilimumab
Eisai to shave 900 from payroll over five years
Fierce Pharma
Thursday, March 3, 2011 - 12:12pm
tags:
layoffs, Eisai
Targacept, Glaxo end alliance
Bizjournals.com
Thursday, March 3, 2011 - 11:34am
tags:
GSK, Targacept

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Novo Nordisk's Canadian Mistake
In the Pipeline
The Bethesda Declaration
In the Pipeline
Taurine and Aging: Is There Anything to It?
In the Pipeline
Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.